Liquidia Corporation stock is up 11.92% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
27 Oct 19:53 | 19 Apr, 2024 | 7.50 | 488 | ||
09 Nov 14:57 | 19 Apr, 2024 | 7.50 | 2844 | ||
17 Nov 20:37 | 19 Jan, 2024 | 2.50 | 132 | ||
20 Nov 15:51 | 19 Jan, 2024 | 10.00 | 207 | ||
20 Nov 15:52 | 19 Jan, 2024 | 10.00 | 207 | ||
20 Nov 15:55 | 19 Jan, 2024 | 10.00 | 207 | ||
21 Nov 19:53 | 19 Apr, 2024 | 5.00 | 672 | ||
27 Nov 15:45 | 17 Jan, 2025 | 5.00 | 2696 | ||
29 Nov 14:38 | 19 Apr, 2024 | 10.00 | 1075 | ||
01 Dec 16:16 | 19 Apr, 2024 | 7.50 | 4187 |
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics.